Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships.

@article{Dholakia2013ResectionOB,
  title={Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships.},
  author={Avani S. Dholakia and Amy Hacker-Prietz and Aaron Tyler Wild and Siva P. Raman and Laura D Wood and Peng Huang and Daniel A. Laheru and Lei Zheng and Ana de Jesus-Acosta and Dung T Le and Richard David Schulick and Barish H. Edil and Susannah G. Ellsworth and Timothy M Pawlik and Christine A Iacobuzio-Donahue and Ralph H. Hruban and John L. Cameron and Elliot K. Fishman and Christopher L. Wolfgang and Joseph M. Herman},
  journal={Journal of radiation oncology},
  year={2013},
  volume={2 4},
  pages={413-425}
}
OBJECTIVE Neoadjuvant therapy increases rates of margin-negative resection of borderline resectable pancreatic ductal adenocarcinoma (BL-PDAC). Criteria for BL-PDAC resection following neoadjuvant chemotherapy and radiation therapy (NCRT) have not been clearly defined. METHODS Fifty consecutive patients with BL-PDAC who received NCRT from 2007 to 2012 were identified. Computed tomography (CT) scans pre- and post-treatment were centrally reviewed. RESULTS Twenty-nine patients (58… CONTINUE READING